Unknown PHASE2/PHASE3 INTERVENTIONAL 3-arm NCT01848873

Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine

Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine in Patients With Mild to Moderate Hypertension and Hyperhomocysteinemia ：a Double-blind Randomized Controlled Trial

Sponsor: Anhui Medical University

Conditions Essential Hypertension

Interventions Amlodipine amlodipine-FA tablet ,high dose group amlodipine-FA tablet, low dose group

Updated 9 times since 2017 Last updated: May 7, 2013 Started: Jan 31, 2013 Primary completion: Aug 31, 2013 Completion: Aug 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Essential Hypertension and is currently ongoing. Anhui Medical University leads this study, which shows 9 recorded versions since 2013 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE2/PHASE3
Feb 2025 — Sep 2025 [monthly]

Unknown PHASE2/PHASE3
Sep 2024 — Feb 2025 [monthly]

Unknown PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2/PHASE3

Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2_PHASE3

▶ Show 4 earlier versions

Sep 2020 — Jan 2021 [monthly]

Unknown Status PHASE2_PHASE3
Dec 2019 — Sep 2020 [monthly]

Unknown Status PHASE2_PHASE3
Jun 2018 — Dec 2019 [monthly]

Unknown Status PHASE2_PHASE3
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2_PHASE3

First recorded

Jan 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Anhui Medical University
Capital Medical University
China Medical University, China
Chinese PLA General Hospital
First Affiliated Hospital of Fujian Medical University
First Affiliated Hospital of Harbin Medical University
Fudan University
Guangdong Provincial People's Hospital
Huazhong University of Science and Technology
Nanchang University
Peking University First Hospital
Ruijin Hospital
Second Affiliated Hospital, School of Medicine, Zhejiang University
Shenzhen Ausa Pharmed Co.,Ltd
West China Hospital
Xi'an Jiaotong University
Xuzhou Medical University

Data source: Shenzhen Ausa Pharmed Co.,Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Beijing, China , Chengdu, China , Fuzhou, China , Guangzhou, China , Haibin, China , Hangzhou, China , Hefei, China , Nanchang, China , Shanghai, China , Shenyang, China and 3 more locations